Continuus Pharmaceuticals
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
25r Olympia Ave, Woburn, Massachusetts, ...Phone Number
(781) 281-0099Website
www.continuuspharma.comRevenue
$16.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Continuus Pharmaceuticals
CONTINUUS Pharmaceuticals is a spin-out company from a multi-year collaboration between MIT and Novartis. The company specializes in end-to-end Integrated Continuous Manufacturing (ICM), with the application of novel process technologies that enable the rapid production of pharmaceuticals at significantly reduced costs and better quality assurance. With ICM, the company will improve affordability and accessibility of pharmaceuticals on a global scale.Explore more
Continuus Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Continuus Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Continuus Pharmaceuticals
Earning: See what the market has to say on Continuus Pharmaceuticals recently announced quarterly report
Click to see if Continuus Pharmaceuticals had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Continuus Pharmaceuticals has new funding data
Continuus Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Continuus Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Continuus Pharmaceuticals launches new products
Website visits: Recent activity has been detected on your website
Check out if Continuus Pharmaceuticals is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Continuus Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to Continuus Pharmaceuticals
Compare insights from companies similar to Continuus Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Continuus Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Continuus Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Continuus Pharmaceuticals.
Continuus Pharmaceuticals financials insights
Gather financial insights about Continuus Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Series A
$2.5M
2019
Series B
$5M
2020
Debt
$350K
Continuus Pharmaceuticals Tech Stack
A closer look at the technologies used by Continuus Pharmaceuticals
Most Recent Scoops
Event
Product Marketing, Events, Training, Sales, Logistics / Supply Chain, Pharmaceuticals, Clinical Operations, Field Marketing, Manufacturing Operations, Operations
Event
Product Marketing, Events, Training, Sales, Logistics / Supply Chain, Pharmaceuticals, Clinical Operations, Field Marketing, Manufacturing Operations, Operations
Executive Move
Board of Directors
Lateral Move
Executive Move
Elizabeth Pool has been appointed as Head of Human Resources.
Funding
Continuus Pharmaceuticals News & Media
Continuus Pharmaceuticals Embraces Digital Validation
SAN FRANCISCO, March 14, 2023 /PRNewswire/ -- ValGenesis, Inc., the market leader in enterprise validation lifecycle management solutions, announced that Continuus Pharmaceuticals, an end-to-end integrated continuous manufacturing (ICM) company, successfully went live with the ValGenesis...CONTINUUS Pharmaceuticals Secures $69.3 Million Government Contract to Manufacture Critical Medicines in the U.S.
WOBURN, Mass., Jan. 21, 2021 /PRNewswire/ -- CONTINUUS Pharmaceuticals Inc., an innovator in transforming production of small-molecule pharmaceuticals with its proprietary Integrated Continuous Manufacturing (ICM) technology, today announced receipt of a $69.3 million U.S. government...CONTINUUS Pharmaceuticals Secures $69.3 Million Government Contract to Manufacture Critical ...
/PRNewswire/ -- CONTINUUS Pharmaceuticals Inc., an innovator in transforming production of small-molecule pharmaceuticals with its proprietary Integrated...CONTINUUS Pharmaceuticals Raises $5 M in Series B Round, Led by Mark Bamforth Who Will Join the Board of Directors
WOBURN, Mass.--(BUSINESS WIRE)--On August 26, 2019, CONTINUUS Pharmaceuticals Inc., a leading technology company working on continuous manufacturing of pharmaceuticals, completed a $5 M Series B financing. This round was led by Mark Bamforth, President & CEO at Arranta Bio, with participation by IMA Industria Macchine Automatiche and other investors from previous rounds. Bamforth will also join the Board of Directors of CONTINUUS, bringing decades of experience in commercial pharmaceutical
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Continuus Pharmaceuticals
Sign Up For FreeTo access detailed company insights
CONTINUUS Pharmaceuticals is a spin-out company from a multi-year collaboration between MIT and Novartis. The company specializes in end-to-end Integrated Continuous Manufacturing (ICM), with the application of novel process technologies that enable the rapid production of pharmaceuticals at significantly reduced costs and better quality assurance.... Read More
